Home › Depression › Pennsylvania › Scranton
Depression clinical trials in Scranton, PA
3 studies for Depression are looking for participants at sites in and around Scranton (within about 30 miles). Open a study to see who can join and how to contact the study team.
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Geisinger Cancer Center Dickson City, Dickson City · 5 mi away
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Recruiting
- Scranton Medical Institutes, Moosic · 5 mi away
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- Scranton Medical Institute, LLC, Moosic · 5 mi away
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA51 studies
- New York City, NY46 studies
- Philadelphia, PA25 studies
- Atlanta, GA23 studies
- Chicago, IL23 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Scranton
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Prostate Cancer5 studies
- Heart Failure4 studies
- Bladder Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.